News Focus
News Focus
Followers 1
Posts 177
Boards Moderated 0
Alias Born 04/14/2004

Re: None

Monday, 11/01/2004 11:13:14 AM

Monday, November 01, 2004 11:13:14 AM

Post# of 270443
EPMN: on the move due to heightened investor confidence. EPMN is the only biotechnology that has conducted cancer vaccine research on humans, AND EVERY TEST SO FAR SUCCESSFUL. Real chance of having a commercially available vaccine from them very high, pretty promising potential IMO. Stock is on the move.

http://finance.yahoo.com/q?s=epmn

ALL in my humble opinion, It's good that you do your DD. Cheers!

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today